How do I find recruiting Hemophilia clinical trials?

Corterve aggregates actively recruiting Hemophilia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.

Are Hemophilia clinical trials free to join?

Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.

Who can take part in a Hemophilia clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Hemophilia Clinical Trials

Hemophilia clinical trials are research studies evaluating new treatments, therapies, and approaches for hemophilia. Corterve aggregates actively recruiting Hemophilia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility criteria. Participation is always voluntary. This page provides general information and is not medical advice; discuss any trial with your healthcare provider before taking part.

Browse all Hemophilia trials Take the free assessment

Recruiting Hemophilia studies

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
NCT06003387PHASE3CSL BehringSan Diego, California
Hemophilia A Research Program
NCT07414511University of WashingtonSeattle, Washington
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
NCT07080905PHASE3CSL BehringOrange, California
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
NCT04398628American Thrombosis and Hemostasis NetworkPhoenix, Arizona
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
NCT07416604PHASE3Hoffmann-La RocheOrange, California
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
NCT05936580PHASE4OctapharmaSan Antonio, Texas
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
NCT04131036Washington Institute for CoagulationLos Angeles, California
ATHNdataset Registry
NCT06820515American Thrombosis and Hemostasis NetworkHickory, North Carolina
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT04278404Duke UniversityPhoenix, Arizona
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
NCT06008938CSL BehringRochester, New York
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
NCT07226206PHASE1, PHASE2Hoffmann-La RocheOrange, California
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460PHASE3SanofiLos Angeles, California

See all 26 recruiting Hemophilia trials →

Hemophilia trials by state

Hemophilia trials by metro

Frequently asked questions

How do I find recruiting Hemophilia clinical trials?: Corterve aggregates actively recruiting Hemophilia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
Are Hemophilia clinical trials free to join?: Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
Who can take part in a Hemophilia clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.